Crescent's European Pharmaceutical Platform
Crescent International is Crescent Pharmaceutical Group's European operation, based in Malta and established to support the Group's continued expansion across European and international pharmaceutical markets. The business provides Crescent with an established European platform for product licensing, Regulatory Affairs, market development and the future commercialisation of medicines across the European Union.
As part of Crescent Pharmaceutical Group, Crescent International is supported by the Group's pharmaceutical development, manufacturing, regulatory and supply capabilities, providing a direct connection between Crescent's growing product portfolio and new international markets.
Crescent International forms an important part of the Group's international growth strategy. The business has established a portfolio of Marketing Authorisations in Malta, creating a foundation from which Crescent can progressively extend its product portfolio into additional European markets. This approach enables Crescent to combine ownership and management of pharmaceutical intellectual property with the development, manufacturing and regulatory capabilities available across the wider Group.
European Headquarters
Based in Malta, Crescent International provides the Group with an established presence within the European Union.
European Portfolio
A growing portfolio of European Marketing Authorisations supports Crescent's continued expansion across EU markets.
International Reach
Supporting the development of Crescent's presence across European and wider international pharmaceutical markets.
Distribution
International supply supported through established air, sea and road freight networks and logistics partners.
Regulatory Capability
Supporting European product registration, licence maintenance and the regulatory management of medicines throughout their lifecycle.
Crescent International's Role in the Group
European Regulatory Capability
Expanding pharmaceutical products across Europe requires sustained regulatory management throughout the product lifecycle. Crescent International works alongside the Group's Regulatory Affairs and Quality teams to support the registration, maintenance and management of products intended for European markets. This provides Crescent with a dedicated European regulatory presence while allowing product development, manufacturing and supply activities to draw upon the complementary capabilities of the wider Pharmaceutical Group.
Connecting Development with European Markets
Crescent's international strategy is supported by a combination of in-house pharmaceutical development, global manufacturing and qualified contract development and manufacturing partners. Crescent International provides the European market platform within this wider model, helping create a route through which products developed or acquired by the Group can progress towards registration and commercial supply in European markets. The result is a scalable approach to international expansion built around product ownership, regulatory capability and access to diversified manufacturing and supply routes.
Expanding Beyond the UK
Crescent Pharmaceutical Group continues to develop opportunities beyond its established UK business. From its base in Malta, Crescent International supports the Group's objective of bringing a broader portfolio of high-quality generic medicines to additional markets while developing long-term relationships with pharmaceutical customers and commercial partners. Its role will continue to grow as Crescent expands its portfolio, progresses further European registrations and develops its international commercial presence.